Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

Completed · Phase 4

Conditions studied: Open Angle Glaucoma, Ocular Hypertension

In brief

This study will evaluate hyperemia and ocular surface tolerability in patients on prostaglandin analogues

Key facts

Study ID

NCT00539526

Run by

Allergan

People needed

106

Starts

2007-09-01

Expected to finish

2008-09-01

Last updated by the study team

2019-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of open-angle glaucoma (pseudoexfoliative or pigmentary glaucomas are allowed) or ocular hypertension

You may not qualify if…

• Known contraindication to latanoprost, bimatoprost or travoprost
• Uncontrolled systemic disease
• Active ocular disease other than glaucoma or ocular hypertension
• Pregnant or lactating women or women of childbearing potential NOT utilizing a medically acceptable form of birth control

Where it is running

• Study site — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.